IDSA 2026 Guidance Makes Sulbactam-Durlobactam the Priority for CRAB Infections
Published . Updated .
David Altarac, MD, discusses the 2026 IDSA guidance, which prioritizes sulbactam-durlobactam plus a carbapenem for invasive carbapenem-resistant Acinetobacter infections.
Directly affected
- No company is named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
IDSA 2026 Guidance Makes Sulbactam-Durlobactam the Priority for CRAB Infections Contagion Live
Source: Contagion Live
This story
12 out of 100
“IDSA 2026 Guidance Makes Sulbactam-Durlobactam the Priority for CRAB Infections” scores 12 out of 100. The score uses 1 sources.